Become a Partner
“Many of the medical challenges we face today are bigger than any one company and country, making partnerships essential to the successful development of vaccines to prevent and treat infectious diseases”.
Wayne Pisano
President and CEO, Sanofi Pasteur
Sanofi Pasteur is interested in partners who will share our pursuit of innovation and our drive for excellence, while becoming a part of our market success story. We welcome the opportunity to evaluate technologies related to the development and production of human vaccines, both prophylactic and therapeutic, including vaccines for infectious and chronic diseases.
Sanofi Pasteur has a strong commitment to Research and Development partnerships with major universities, research institutes, government bodies, biotechnology companies and contract research organizations. Our collaborations cover virtually all aspects of vaccine development, including early-stage research.
Examples of current partnerships and technology investments include: vaccines for dengue fever, Japanese encephalitis, S. pneumoniae, N. meningitidis B, and M. tuberculosis; pediatric combination vaccines; rabies monoclonal antibodies; large-scale, cell culture-based virus production; adjuvants and immunomodulators; conjugate vaccine production; and vaccine delivery systems.
When partnering with sanofi pasteur, you will interact with a multidisciplinary team that has years of experience in working to ensure that partnerships are executed succesfully and nurtured for the mutual benefit of all parties.
This approach utilizes the value-added sanofi pasteur alliance management capability, which focuses on the relationship by facilitating open communication trust, understanding and clear expectations across the project lifespan. Combined with the technical competency of the alliance, this balance provides a wellrounded environment for your technology to flourish.
